Sunao Manabe
Vorstandsvorsitzender bei DAIICHI SANKYO CO., LTD.
Aktive Positionen von Sunao Manabe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DAIICHI SANKYO CO., LTD. | Vorstandsvorsitzender | 01.06.2019 | - |
| Vorsitzender | - | - | |
| Direktor/Vorstandsmitglied | 01.06.2014 | - | |
| Geschäftsführer | 01.04.2017 | 01.06.2019 | |
| Personalreferent | 01.06.2016 | 01.04.2017 | |
| Corporate Officer/Principal | 01.04.2007 | 01.06.2016 | |
| Präsident | 01.04.2017 | - | |
| Vertrieb & Marketing | 01.04.2015 | 01.04.2016 | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Corporate Officer/Principal | 12.07.2023 | - |
Karriereverlauf von Sunao Manabe
Statistik
International
| Japan | 2 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
International Federation of Pharmaceutical Manufacturers
International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |
- Börse
- Insiders
- Sunao Manabe
- Erfahrung
